Ethnic variations in paraoxonase1 polymorphism in the Malaysian population by Poh, R. & Muniandy, S.
SOUTHEAST ASIAN J TROP MED PUBLIC HEALTH
392 Vol  38  No. 2  March  2007
Correspondence: Rozaida Poh, Department of Mo-
lecular Medicine, Faculty of Medicine, University of
Malaya, 50603 Kuala Lumpur, Malaysia.
ETHNIC VARIATIONS IN PARAOXONASE1 POLYMORPHISM
IN THE MALAYSIAN POPULATION
Rozaida Poh and Sekaran Muniandy
Department of Molecular Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur,
Malaysia
Abstract. The role of high-density lipoprotein associated paraoxonase (PON) 1 in protection against
oxidative stress associated with the development of complications in diabetes mellitus has been
reported. Variations in the PON1 gene, 55LM and 192QR have been described in different popu-
lations. These variations are known to be risk factors for heart disease, especially the L and R
alleles. We have investigated the prevalence of both polymorphisms in the Malaysian population
comprising the three major ethnic groups: Malay, Chinese and Indian, using polymerase chain
reaction followed by restriction endonuclease digestion. The results show the pooled frequen-
cies of L and R alleles were 0.91 and 0.54, respectively, similar to those in the Asian region. The
frequency of the M allele was higher in Indians (p < 0.05), whereas the R allele was higher in both
the Chinese and Malays compared to Indians (p < 0.05), indicating ethnic group-dependent
genetic differences. The most common genotypic combination was LL/QR, followed by LL/RR.
The genotype frequencies for the total Malaysian population showed a significant departure from
Hardy-Weinberg equilibrium for the 55LM (p = 0.013) but not the 192QR (p = 0.056) polymor-
phisms. A strong linkage disequilibrium between L/55 and R/192 alleles was also observed. In
the Malaysian population as a whole, Malays and Chinese showed a higher frequency of the R
allele which is a risk factor for cardiovascular diseases.
INTRODUCTION
Paraoxonase1 (PON1) is an esterase be-
longing to a family of proteins that includes
PON2 and PON3 (Costa et al, 2005). The
genes coding for the PON family are located
on human chromosome 7 (q21.22). PON1 has
two exonic amino acid polymorphisms, one
at position 55 (methionine/leucine; M/L) and
another at position 192 (arginine/glutamine; R/
Q) (Durrington et al, 2001). PON1 is associ-
ated with high-density lipoprotein (HDL) par-
ticles, connotating its role in preventing oxi-
dative damage to low-density lipoprotein (LDL)
particles (Mackness et al, 1998). Purified
PON1 was significantly more efficient than
other enzymes effects on HDL in preventing
oxidation of LDL (Arrol et al, 1996). The pro-
tective effect of HDL has been well described
in arresting the development of coronary heart
disease (CHD), as well as other vascular com-
plications of diabetes (Mackness et al, 2002).
A number of studies have found the R
allele of PON1 to be associated with heart dis-
ease in some populations, whereas others
have not found such an association (Santos
et al, 2005).
Little is known of the prevalence of mu-
tations of the PON1 gene. Furthermore, there
is a lack of information regarding the associa-
tion between allele frequencies and risk fac-
tors for heart disease, especially in diabetics
in the Malaysian population. Thus genotyping
the diabetic individuals for both the PON1
192QR and 55LM polymorphisms may pro-
vide a method for identifying those individuals
at the highest risk for developing complica-
tions. Previous studies have focused on Cau-
casians and some Asian populations, includ-
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ing the Japanese (Odawara et al, 1997) and
Thai populations (Phuntuwate et al, 2005).
The effects of the two polymorphisms on
PON1 activity and concentration in diabetic
patients have previously been reported
(Mackness et al, 1998; Ikeda et al, 1998) with
PON1 activity showing an increase in the or-
der of  the RR>QR>QQ genotypes and
LL>LM>MM genotypes in patients.
The present study evaluates variations in
PON1 polymorphisms in the Malaysian popu-
lation in order to identify specific risk factor




A group of subjects drawn from outpa-
tients who attended the Diabetic Clinic Uni-
versity Malaya Medical Center, Kuala Lumpur,
as well as healthy volunteers residing in
Selangor and Kuala Lumpur were selected.
Some demographic characteristics of these
subjects were recorded.
This study was approved by the Medical
Ethics Committee (MEC) and informed con-
sent was obtained from each subjects in the
study.
Blood sampling and DNA extraction
Venous blood was obtained by a trained
phlebotomist under sterile conditions from
subjects. Genomic DNA was extracted from
whole EDTA blood using a Gene All Blood DNA
Purification kit (General Biosystem, Seoul,
South Korea).
Determination of PON1 genotypes
PON1 genotypes were determined by
PCR-based methods according to previously
published protocols (Richter et al, 2004). For
the polymorphism at position 192, sense
primer 5´ TAT TGT TGC TGT GGG ACC TGA
G 3´ and antisense primer 5´ CAC GCT AAA
CCC AAA TAC ATC TC 3´ which encompass
the 192 polymorphic region of the human
PON1 gene were used. For the polymorphism
at position 55, sense primer 5´ AGA GGA TTC
AGT CTT TGA GGA AA 3´ and antisense
primer 5´ CTG CCA GTC CTA GAA AAC GTT
3´ were used.
PCR reactions were carried out using a
Hybaid Omnigene thermal cycler (Hybaid,
Middlesex, UK). The hot-start PCR reaction
mixture for the PON1-192 polymorphism con-
tained 100 ng of DNA template, 0.5 µM of
each primer, 1.5 mM MgCl2, 200 µM of each
dNTP and 1 unit of Taq DNA polymerase and
hot-start antibody mixture (Biotherm PCR kit,
Genecraft, Germany). The reaction mixture
was denatured for 3 minutes at 93oC, followed
by 35 cycles of 1 minute of denaturation at
93oC, 30 seconds of annealing at 61oC and 1
minute of extension at 72oC. Final extension
was performed for 7 minutes at 72oC.
The resulting 99 bp PCR product was
then digested with 5 units of AlwI restriction
endonuclease (New England Biolabs, Cam-
bridge, MA, USA) overnight at 37oC, followed
by size fractionation with 10 µl matched undi-
gested and digested samples loaded alter-
nately into wells of 4% 0.05 M Tris-borate-
EDTA pH 8.0 horizontal agarose gel contain-
ing 0.5 µg/ml ethidium bromide at a voltage
of 5 V/cm. The R genotype (arginine) contains
a unique AlwI restriction site which resulted in
products of 63 and 36 bp, whereas the Q
genotype (glutamine) was not cut.
For the PON1-55 polymorphism, the PCR
reaction mixture contained 100 ng of DNA
template, 0.5 µM of each primer, 1.5 mM
MgCl2, 200 µM of each dNTP and 1 unit of
Taq DNA polymerase (Biotherm). After dena-
turation for 5 minutes at 94oC, the reaction
mixture was subjected to 35 cycles of 30 sec-
onds of denaturation at 94oC, 30 seconds of
annealing at 61oC and 30 seconds of exten-
sion at 72oC. The final extension time was 7
minutes at 72oC.
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The 386 bp PCR product was digested
with 3 units of NlaIII (New England Biolabs) in
the presence of BSA overnight at 37oC, and
the digested products were separated in 3%
0.05 M Tris-borate-EDTA agarose gels con-
taining 0.5 µg/ml ethidium bromide at a volt-
age of 5 V/cm as above. The L genotype (leu-
cine) did not contain an NlaIII site, whereas
the M genotype (methionine) contained an
NlaIII site, giving rise to products of 296 and
90 bp (Richter et al, 2004).
Statistical analysis
Analysis was performed using SPSS 13.0
for Windows statistical software. One-way
analysis of variance (ANOVA) was used to test
for differences in parameters between ethnicity
and genotypes (Mackness et al, 2000). Com-
putation of allele frequencies and estimation of
Hardy-Weinberg equilibrium and linkage dis-
equilibrium were performed using  GENEPOP
3.4 software (Raymond and Rousset, 1995).
The Markov chain method was employed at
1,000 dememorization steps, 100 batches and
1,000 iterations per batch to obtain an unbi-
ased estimate of the p-value. Haplotype fre-
quencies were computed by Arlequin software
(Schneider et al, 2000) using the expectation-
maximization (EM) algorithm (Slatkin and
Excoffier, 1996).
RESULTS
Demographic characteristics of the study popu-
lation
The study population had a higher per-
centage of women (59%). Malays formed al-
most half the study population at 47%, fol-
lowed by Indians (33%) and Chinese (20%).
The pooled age range was 17-97 years, with
the mean age being 52 ± 13.5 years old. The
subjects who were diabetics made up 52%
while the remaining 48% were non-diabetics.
Genotype and allele frequencies of the PON1
polymorphisms
The frequency of the M allele was higher
in Indians compared to Malays and Chinese (p
< 0.05), whereas the R allele was higher in the
Chinese (R = 0.621) and Malays (R = 0.587)
Ethnic N (%) LLQQ LLQR LLRR LMQQ LMQR LMRR MMQQ L R
group
Malay 133 (47) 19 48 52 8 4 1 1 0.944 0.587
Chinese 58 (20) 9 20 25 1 2 0 1 0.957 0.621
Indian 94 (33) 18 35 15 7 15 0 4 0.839 0.426
Total 285 (100) 46 103 92 16 21 1 6 0.912 0.541
Table 1
Demographic profile and breakdown of PON1 genotype and allele frequencies observed in
three major Malaysian ethnic groups.
PON1-192 100% PON1-55 100%
Genotype QQ (n =68): 24% LL (n =241): 85%
  QR (n =124): 43% LM (n =38): 13%
RR (n =93): 33% MM (n = 6): 2%
Allele Q 0.459 L 0.912
R 0.541 M 0.088
Table 2
Pooled genotype and allele frequencies of the PON1 gene polymorphisms in the study
population.
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compared to Indians (R = 0.426, p < 0.05)
(Table 1). Only seven out of the expected ten
possible genotypic combinations of the two
polymorphisms were seen in this population.
The most common genotype was LL/QR (36%)
followed by LL/RR (32%). Moreover, the LM/
RR genotype, the least frequent of the seven
genotypes, was found in only one subject of
Malay origin. Both MMQR and MMRR geno-
types were absent in the study population. Of
particular significance was the frequency of the
MM/QQ genotype, which was found predomi-
nantly in Indians (67%), but generally of low fre-
quency in the Malaysian population at large.
In the pooled population, the observed fre-
quencies for L, M, Q and R alleles were 0.912,
0.088, 0.459 and 0.541, respectively (Table 2).
The genotype frequencies for the total
Malaysian population showed a significant
departure from HWE for the 55LM (p=0.013)
but not the 192QR (p=0.056) polymorphisms.
A strong linkage disequilibrium between L/55
and R/192 alleles was observed (p<0.0001)
characterized by an excess of LR and LQ
haplotypes (Table 3).
DISCUSSION
The pooled frequency of the R allele was
0.54 in the study population. This is consis-
tent with studies by Sanghera et al (1997), Hu
et al (2003) and Zhang et al (2005) in Chinese
populations (R = 0.57, 0.53, 0.54, respec-
tively). However, this result differed significantly
from the value obtained for the English (R =
0.30; Rice et al, 1997), Asian Indian (R = 0.39,
Sanghera et al, 1998) and Thai (R = 0.29,
Phuntuwate et al, 2005) populations which
were on one end of the frequency spectrum.
It also differed from the value calculated for
the Korean (R = 0.666; Hong et al, 2001),
Bogalusa black (R = 0.67) and the Amerindian
populations (R = 0.73; Santos et al, 2005).
Amerindians showed higher R allele frequency
when compared to Asians. The relatively low
R allele frequency in Thais was unexpected,
given that their geographical neighbors, Ma-
laysians, showed frequencies of R >0.40. Nev-
ertheless, the frequency of the PON1-192R
allele generally ranged from 0.25 in Cauca-
sians of northern European origin, to 0.69 in
some Asian populations (Costa et al, 2005).
The variable distribution of allele frequencies
appeared to be dependent on geographic lo-
cations (Scacchi, 2003) perhaps due to ge-
netic drift, as well as ethnic groups (Sanghera
et al, 1998).
The difference in allele frequencies spe-
cifically for the R allele is underlined by the
fact that this is seen as a risk factor in only
some populations. Various studies of Cauca-
sians have associated PON1-192 polymor-
phism with coronary heart disease risk,
whereas others have not (Ruiz et al, 1995;
Population N LR LQ MR MQ L R
Malaysians 285 0.540 0.371 0.002 0.085 0.912 0.540
Chinesea 142 0.574 0.387 - 0.039 0.961 0.574
Koreansb 191 0.620 0.325 - 0.055 0.945 0.620
Japanesec 2,196 0.666 0.261 - 0.073 0.927 0.666
Amerindiansd 259 0.730 0.237 - 0.033 0.967 0.730
Euro-Brazilianse 101 0.307 0.302 - 0.391 0.609 0.307
Afro-Braziliansf 70 0.465 0.250 0.064 0.222 0.714 0.529
Table 3
Haplotype and allele frequencies of 55LM and 192QR polymorphisms in Malaysians
compared with Asian and Caucasian populations (modified from Santos et al, 2005).
aSanghera et al, 1997; bHong et al, 2001; cYamada et al, 2003; dSantos et al, 2005; e,fAllebrandt et al, 2002
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Serrato et al, 1995). The R allele is a risk fac-
tor for coronary heart disease in Asian Indi-
ans but not in Chinese (Sanghera et al, 1998).
Such inconsistency is probably because the
PON1 codon 192 polymorphism was in link-
age disequilibrium with other functional mu-
tations in a particular haplotype of the PON1
gene (Koda et al, 2004) or nearby genes.
For codon 55 polymorphism, the preva-
lence of the PON1-55 L allele (L = 0.912) in
this investigation is similar to that found in the
Japanese (L = 0.927; Yamada et al, 2003),
Singaporean Chinese (L = 0.961; Sanghera
et al, 1998) Han Chinese (Zhang et al, 2006),
Amerindians (L = 0.967; Santos et al, 2005),
and Thais (L = 0.950, Phuntuwate et al, 2005).
Comparison of the M allele frequencies for
Malaysian Chinese (M = 0.161) and Indians
(M = 0.043) with their Singaporean counter-
parts showed similar frequencies (Singaporean
Chinese, M = 0.202; Singaporean Indians, M
= 0.036, respectively) although differing dis-
tinctly between the two ethnic groups. This
emphasizes the local and ethnic differences
in gene frquencies among populations. The
generally low frequency of the M allele was
such that in some studies the MM genotype
was not observed at all (Santos et al, 2005).
The prevalence of the L allele in this study was
higher than that found in the western white
(0.640) (Brophy et al, 2001) and Italian popu-
lations (0.63) (Arca et al, 2002).
Only seven genotypes were observed in
this study, and this was probably due to the
strong linkage disequilibrium between the two
polymorphic sites (only 8.6 kb apart) across
the populations (Santos et al, 2005). As the R
allele frequency is higher in Malaysians, it is
reasonable to expect a higher frequency of the
LL/QR (36%) and LL/RR (32%) genotypes,
compared to LLQQ (43%) and LLQR (41%)
for Thais. There were no MMQR or MMRR car-
riers observed, suggesting that this genotype
combination is very rare in Malaysians; this is
similar to the low incidence observed in the
Thai population. Only MMQQ genotypes were
observed for the M allele in the present study.
Kao et al (2002) found that patients with ret-
inopathy had a higher frequency of the LL
genotype than those without retinopathy in a
diabetic population. These findings suggested
that the M allele may have a protective role.
Conversely, the L allele was regarded as a risk
factor for diabetic complications.
The present study is the first to record
the distribution of the 55LM and 192QR geno-
type frequencies of the PON1 gene in three
major Malaysian ethnic groups. The Malays
and Chinese had a higher frequency of the R
allele, which is considered a risk factor for car-
diovascular disease in a number of popula-
tions from previous studies.
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